VS Peps · Certificate № JN-260520-8939

Certificate of Analysis

Compound identity

CJC

CJC-1295 (no DAC)

Modified GHRH analog · 5mg lyophilized

Batch identifiers

Batch IDJN-260520-8939
Lab referenceLR-01963
Test date2026-05-20
Format5mg · lyophilized

HPLC Analysis

High-Performance Liquid Chromatography

Reported purity

98.9%

Area under the target peak as a percentage of total area.

Batch · 2026-05-20Janoshik Analytical · HPLC
98.9%CJC2 MIN5 MIN8 MIN12 MIN

Identity verification

Compound nameCJC-1295 (no DAC)
Editorial codeCJC
Molecular formConfirmed by MS
Test methodRP-HPLC / UV-Vis
Reference standardIn-house standard, characterized
Storage at testLyophilized, sealed vial, RT

Structure

29residues
3-letter notation

29-residue peptide. Full sequence elided for readability — downloadable on the certificate of analysis.

Modifications

  • 01D-Ala at position 2
  • 02Gln at position 8
  • 03Ala at position 15
  • 04Leu at position 27

Sourcing & storage

Sourcing chain

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & handling

Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 14 days. Research use only.

Lab analyst signature

Janoshik Analytical

Verified · 2026-05-20

Document control

Certificate № JN-260520-8939Issued 2026-05-20Format RP-HPLC / UVDistribution Per-product page

Research use only. This certificate documents analytical results for the batch identified above. Products are sold strictly for laboratory and research applications and are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. The information herein is provided in good faith based on third-party HPLC analysis but is not a guarantee or warranty. See Research Use Disclaimer for full terms.